Has Catherine Poulos received payments from drug or device companies?

Yes. Drug and device makers reported $4,918 in general payments to Catherine Poulos across 201 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Catherine Poulos did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Catherine Poulos come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Catherine Poulos

Psychiatric/Mental Health · Hampton Bays, NYNPI 1396997672

Payments from drug & device makers

$4,918in general payments, 2019–2025

Across 201 payments — averaging $24.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Lundbeck LLC$675
Alkermes, Inc.$476
Neurocrine Biosciences, Inc.$418
Takeda Pharmaceuticals U.S.A., Inc.$411
Otsuka America Pharmaceutical, Inc.$361
plus $2K from 11 others

What the payments were for

Food & beverage$4,918100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	40	$1,016
Lundbeck LLC	36	$675
Alkermes, Inc.	10	$476
Neurocrine Biosciences, Inc.	13	$418
Takeda Pharmaceuticals U.S.A., Inc.	21	$411
Otsuka America Pharmaceutical, Inc.	16	$361
Corium, LLC	19	$298
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	8	$244
Axsome Therapeutics, Inc.	5	$240
Johnson & Johnson	8	$206
Vanda Pharmaceuticals Inc.	7	$177
Teva Pharmaceuticals USA, Inc.	6	$131
Sunovion Pharmaceuticals Inc.	4	$83
E.r. Squibb & Sons, L.L.C.	3	$69
Supernus Pharmaceuticals, Inc.	2	$53
Almatica Pharma LLC	2	$34
Biogen	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,918 in reported general payments places this provider in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RexultiBrexpiprazole	14	$20,540
Vilazodone Hcl	43	$3,391
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	30	$2,053
Duloxetine Hcl	29	$1,729
Aripiprazole	30	$1,400
Mirtazapine	20	$750
Quetiapine Fumarate	43	$678
Sertraline Hcl	44	$640
Venlafaxine Hcl ErVenlafaxine Hcl	30	$547
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	22	$512
Gabapentin	27	$414
Escitalopram Oxalate	43	$408
Fluoxetine Hcl	51	$396
Alprazolam	61	$383
Clonazepam	73	$362

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti	$361	$20,54014 claims
Almatica Pharma LLCSertraline Hcl	$34	$64044 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Hampton Bays

Glenn HannDansville$1.3M
Tammy RussoNiskayuna$568K
Carrie EdickSchenectady$484K
Eric SpronzCentereach$448K
Terry Jo Brooks-DevlinTonawanda$176K
Kevin SiewersStaten Island$155K
Daniel BreeyearNiskayuna$149K
Mary OlsonNew York$142K
Elijah StevensBinghamton$131K
Kayanna JonasFar Rockaway$93K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →